The bio corporation PROTEINA, which is set to list on the KOSDAQ, gathered 4.7 trillion won in subscriptions from the public offering.
On the 21st, PROTEINA announced that it recorded a competitive ratio of 1,797.61 to 1 in the public offerings conducted over two trading days from the 18th to this day.
A total of 674,105,210 shares were subscribed for the 375,000 shares allocated to individual investors. The subscription deposit was approximately 4.7187 trillion won.
PROTEINA was founded by Professor Yoon Tae-young of the Department of Life Sciences at Seoul National University in 2015 while he was at the Korea Advanced Institute of Science and Technology (KAIST). It has protein-protein interaction (PPI) analysis technology necessary for new drug development.
The expected market capitalization based on the confirmed offering price after the listing is 151 billion won, and Korea Investment & Securities Ltd. is acting as the underwriter.
Previously, PROTEINA recorded a competitive ratio of 1,199 to 1 in demand forecasting for institutional investors and finalized the offering price at 14,000 won, the upper limit of the hoped range (11,000 won to 14,000 won).
PROTEINA's CEO Yoon Tae-young noted, "With the KOSDAQ listing, we will expand the application scope of our PPI big data generation platform and enhance cooperation with global pharmaceutical and biotech companies."
Meanwhile, PROTEINA will be listed on the KOSDAQ market on the 29th after capital injection.